Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 21-28 of 28 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2015TIDEL-II: first-line use of imatinib in CML with early switch to nilotinib for failure to achieve time-dependent molecular targetsYeung, D.; Osborn, M.; White, D.; Branford, S.; Braley, J.; Herschtal, A.; Kornhauser, M.; Issa, S.; Hiwase, D.; Hertzberg, M.; Schwarer, A.; Filshie, R.; Arthur, C.; Kwan, Y.; Trotman, J.; Forsyth, C.; Taper, J.; Ross, D.; Beresford, J.; Tam, C.; et al.
2008Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trialDavis, S.; Donnan, G.; Parsons, M.; Levi, C.; Butcher, K.; Peeters, A.; Barber, P.; Bladin, C.; De Silva, D.; Byrnes, G.; Chalk, J.; Fink, J.; Kimber, T.; Schultz, D.; Hand, P.; Frayne, J.; Hankey, G.; Muir, K.; Gerraty, R.; Tress, B.; et al.
2011Apixaban versus Warfarin in patients with atrial fibrillationGranger, C.; Alexander, J.; McMurray, J.; Lopes, R.; Hylek, E.; Hanna, M.; Al-Khalidi, H.; Ansell, J.; Avezum, A.; Atar, D.; Bahit, M.; Diaz, R.; Easton, J.; Ezekowitz, J.; Garcia, D.; Geraldes, M.; Gersh, B.; Golitsyn, S.; Goto, S.; Hermosillo, A.; et al.
2008Comparable outcomes in nonsecretory and secretory multiple myeloma after autologous stem cell transplantationKumar, S.; Perez, W.; Zhang, M.; Ballen, K.; Bashey, A.; To, L.; Bredeson, C.; Cairo, M.; Elfenbein, G.; Freytes, C.; Gale, R.; Gibson, J.; Kyle, R.; Lacy, M.; Lazarus, H.; McCarthy, P.; Milone, G.; Moreb, J.; Pavlovsky, S.; Reece, D.; et al.
2016Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ARTLambert-Niclot, S.; George, E.; Pozniak, A.; White, E.; Schwimmer, C.; Jessen, H.; Johnson, M.; Dunn, D.; Perno, C.; Clotet, B.; Plettenberg, A.; Blaxhult, A.; Palmisano, L.; Wittkop, L.; Calvez, V.; Marcelin, A.; Raffi, F.; Dedes, N.; Chěne, G.; Allavena, C.; et al.
2015Analysis of KRAS/NRAS mutations in a phase III study of panitumumab with FOLFIRI compared with FOLFIRI zlone as second-line treatment for metastatic colorectal cancerPeeters, M.; Oliner, K.; Price, T.; Cervantes, A.; Sobrero, A.; Ducreux, M.; Hotko, Y.; André, T.; Chan, E.; Lordick, F.; Punt, C.; Strickland, A.; Wilson, G.; Ciuleanu, T.; Roman, L.; Van Cutsem, E.; He, P.; Yu, H.; Koukakis, R.; Terwey, J.; et al.
2017Laparoscopy to predict the result of primary cytoreductive surgery in patients with advanced ovarian cancer: a randomized controlled trialRutten, M.; Van Meurs, H.; Van De Vrie, R.; Gaarenstroom, K.; Naaktgeboren, C.; Van Gorp, T.; Brugge, H.; Hofhuis, W.; Schreuder, H.; Arts, H.; Zusterzeel, P.; Pijnenborg, J.; Van Haaften, M.; Fons, G.; Engelen, M.; Boss, E.; Vos, M.; Gerestein, K.; Schutter, E.; Opmeer, B.; et al.
2019Secondary and Exploratory Outcomes of the Subthreshold Nanosecond Laser Intervention Randomized Trial in Age-Related Macular Degeneration: A LEAD Study ReportWu, Z.; Luu, C.D.; Hodgson, L.A.B.; Caruso, E.; Brassington, K.H.; Tindill, N.; Aung, K.Z.; Harper, C.A.; Wickremasinghe, S.S.; Sandhu, S.S.; McGuinness, M.B.; Chen, F.K.; Chakravarthy, U.; Arnold, J.J.; Heriot, W.J.; Durkin, S.R.; Wintergerst, M.W.M.; Gorgi Zadeh, S.; Schultz, T.; Finger, R.P.; et al.